Position in NBIX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$235,113
+$18,797 QoQ
Shares Held
1,395
-15.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#579
of 772 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DRIVE WEALTH MANAGEMENT, LLC holds $1,932,764 across 8 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (12.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
3,613 | $400,825 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,161 | $242,613 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
438 | $237,321 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,395 | $235,113 | |
| 5 | HLN |
Haleon plc
|
24,972 | $232,988 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
12,648 | $202,747 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
3,147 | $201,250 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
12,416 | $179,907 |
All Filings in NBIX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $235,113 | 1,395 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $216,316 | 1,642 | Shares | Sole | 2026-04-14 | |
| No filing history on record for this holder in this stock. | ||||||